Projects
Active Studies/Projects
Stage 2 Clinical Trial: eTMS for PTSD
This project is currently actively recruiting.
More information is available via the clinicaltrials.gov registration for this study.
Cerebral oxygenation indexed via fMRI to catalog the time course to recovery from hypoxic exposure
This study is actively recruiting. Use the about us page to reach out for more information.
Enhancing Plasticity in Inferiotemporal Cortex
This study is actively recruiting. Use the about us page to reach out for more information.
Mechanisms Evoking Post-Sortie Systemic Inflammation, Reduced Prefrontal Cortical Activity and Cognitive Fatigue
This study is not yet recruiting. Use the about us page to reach out for more information.
Hemodynamic response to hypoxia: extended recovery
Hemodynamic response to hypoxia following a hyperoxic pre-breathe
Dominantly Inherited Alzheimer Network Trial Unit (DIAN-TU)
This ongoing study is testing the safety and effectiveness of several experimental drugs to slow the progression of cognitive impairment in people with an inherited Alzheimer's disease-causing gene mutation. Specifically, mutations in presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein (APP) genes are associated with inherited Alzheimer's disease. All participants will be tested to determine if they have one of the mutations. Participants found to have one of the mutations will be randomly assigned to receive injections of one of the study drugs. Those participants who do not have a mutation will be randomly assigned to receive injections of either a study drug or a placebo. Injections will be given every four weeks for up to 208 weeks. Researchers will measure changes in cognition, blood and spinal fluid biomarkers, abnormal amyloid and tau protein in the brain, and brain glucose metabolism. Measurements will be done at the start of the study and then again at weeks 52, 104, 156, and 208. The study, called DIAN-TU, will test several different study drugs, starting with solanezumab. More information can be found here.
Completed Studies/Projects
Stage 1 Clinical Trial: eTMS for PTSD
Assessment of MRI Measurement Stability
Neurophysiological Effects of Non-Standard Delivery Pressure
This study has been presented at AsMA 2022 and AsMA 2024, and was the topic of a panel at NATO Ramstein Aerospace Medicine Summit (RAMS) held in Garmisch-Partenkirchen, Germany in 2024.
